Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Constellation Healthcare to exit AIM in £247mln deal

Constellation, a consolidator of billing businesses used by doctors in the US, is being acquired by investment US firm CC Capital and founder and chief executive Paul Parmar.
Constellation Healthcare to exit AIM in £247mln deal
It has been a brief stay on AIM, though investors at the IPO will double their money.

Constellation Healthcare Technologies Inc (LON:CHT) is being taken private less than two years after listing on AIM in a deal that values the business at £247mln.

Constellation, a consolidator of billing businesses used by doctors in the US, is being acquired by investment US firm CC Capital and founder and chief executive Paul Parmar.

They have tabled an offer worth £2.70 a share, which is a 45% premium to last night’s closing price. The deal, which includes a promissory note worth 34.5p a share, has been recommended the board.

Chairman John Johnson said: "This deal will provide the capital that Constellation Healthcare Technologies needs to grow its business at the rate that changes in its market demands while at the same time giving an excellent return to shareholders since IPO."

Investors who backed the company when it listed in December 2014 will double their money.

View full CHT profile View Profile

Constellation Healthcare Technologies, Inc. Timeline

Related Articles

cells
July 30 2018
Life science generally is developing at an incredible speed, says Joe Anderson
1527682514_angel-delight.jpg
May 30 2018
The latest fundraiser underscores the fact the life sciences business is well supported in the City
Workers at CERN
August 02 2018
Private banks and healthcare groups took part in the share placing

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use